DE60129549D1 - Verbesserte nukleinsäure-modifizierende enzyme - Google Patents

Verbesserte nukleinsäure-modifizierende enzyme

Info

Publication number
DE60129549D1
DE60129549D1 DE60129549T DE60129549T DE60129549D1 DE 60129549 D1 DE60129549 D1 DE 60129549D1 DE 60129549 T DE60129549 T DE 60129549T DE 60129549 T DE60129549 T DE 60129549T DE 60129549 D1 DE60129549 D1 DE 60129549D1
Authority
DE
Germany
Prior art keywords
nucleic acid
modifying enzymes
acid modifying
improved nucleic
enzyme
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60129549T
Other languages
English (en)
Other versions
DE60129549T2 (de
Inventor
Yan Wang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bio Rad Laboratories Inc
Original Assignee
Bio Rad Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Rad Laboratories Inc filed Critical Bio Rad Laboratories Inc
Publication of DE60129549D1 publication Critical patent/DE60129549D1/de
Application granted granted Critical
Publication of DE60129549T2 publication Critical patent/DE60129549T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241—Nucleotidyltransferases (2.7.7)
    • C12N9/1276—RNA-directed DNA polymerase (2.7.7.49), i.e. reverse transcriptase or telomerase
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241—Nucleotidyltransferases (2.7.7)
    • C12N9/1252—DNA-directed DNA polymerase (2.7.7.7), i.e. DNA replicase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/96—Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/30—Nucleotides
    • C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
    • C12Y207/07—Nucleotidyltransferases (2.7.7)
    • C12Y207/07049—RNA-directed DNA polymerase (2.7.7.49), i.e. telomerase or reverse-transcriptase
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/80—Fusion polypeptide containing a DNA binding domain, e.g. Lacl or Tet-repressor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
    • C12Y207/07—Nucleotidyltransferases (2.7.7)
    • C12Y207/07007—DNA-directed DNA polymerase (2.7.7.7), i.e. DNA replicase
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/52—Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts
DE60129549T 2000-05-26 2001-05-29 Verbesserte nukleinsäure-modifizierende enzyme Expired - Lifetime DE60129549T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US20756700P 2000-05-26 2000-05-26
US207567P 2000-05-26
US640958 2000-08-16
US09/640,958 US6627424B1 (en) 2000-05-26 2000-08-16 Nucleic acid modifying enzymes
PCT/US2001/017492 WO2001092501A1 (en) 2000-05-26 2001-05-29 Improved nucleic acid modifying enzymes

Publications (2)

Publication Number Publication Date
DE60129549D1 true DE60129549D1 (de) 2007-09-06
DE60129549T2 DE60129549T2 (de) 2008-04-24

Family

ID=26902363

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60129549T Expired - Lifetime DE60129549T2 (de) 2000-05-26 2001-05-29 Verbesserte nukleinsäure-modifizierende enzyme

Country Status (10)

Country Link
US (10) US6627424B1 (de)
EP (1) EP1283875B1 (de)
JP (2) JP4405725B2 (de)
AT (1) ATE368104T1 (de)
AU (2) AU7503901A (de)
CA (1) CA2409417C (de)
DE (1) DE60129549T2 (de)
DK (1) DK1283875T3 (de)
ES (1) ES2291322T3 (de)
WO (1) WO2001092501A1 (de)

Families Citing this family (114)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040009486A1 (en) * 1999-10-29 2004-01-15 Sorge Joseph A. Compositions and methods utilizing DNA polymerases
US20050123940A1 (en) * 1999-10-29 2005-06-09 Stratagene California Compositions and methods for synthesizing cDNA
US20030228616A1 (en) * 1999-10-29 2003-12-11 Stratagene DNA polymerase mutants with reverse transcriptase activity
US8268605B2 (en) 1999-10-29 2012-09-18 Agilent Technologies, Inc. Compositions and methods utilizing DNA polymerases
DE60133992D1 (de) * 2000-02-17 2008-06-26 Qiagen Gmbh Thermostabile chimäre nucleinsäurepolymerasen und ihre verwendungen
US6627424B1 (en) 2000-05-26 2003-09-30 Mj Bioworks, Inc. Nucleic acid modifying enzymes
DE10049211A1 (de) * 2000-10-05 2002-04-18 Qiagen Gmbh Thermostabile Polymerase aus Thermococcus pacificus
US7211414B2 (en) 2000-12-01 2007-05-01 Visigen Biotechnologies, Inc. Enzymatic nucleic acid synthesis: compositions and methods for altering monomer incorporation fidelity
AU2002351193A1 (en) * 2001-11-28 2003-06-10 Mj Bioworks Incorporated Parallel polymorphism scoring by amplification and error correction
EP1456394B2 (de) 2001-11-28 2011-04-27 Bio-Rad Laboratories, Inc. Verfahren zur verwendung verbesserter polymerasen
US20060234227A1 (en) * 2002-05-14 2006-10-19 Alexei Slesarev Helix-hairpin-helix motifs to manipulate properties of dna processing enzymes
CA2518588A1 (en) * 2002-07-25 2004-02-05 Mj Bioworks Incorporated Hybrid dna polymerase proteins having increased polymerase to exonuclease activity
US7560260B2 (en) * 2002-07-25 2009-07-14 Bio-Rad Laboratories, Inc. Compositions with polymerase activity
US7666645B2 (en) * 2002-10-23 2010-02-23 Bio-Rad Laboratories, Inc. Sso7-polymerase conjugate proteins
JP2006507012A (ja) * 2002-10-25 2006-03-02 ストラタジーン カリフォルニア 減少した塩基類似体検出活性を有するｄｎａポリメラーゼ
US8283148B2 (en) 2002-10-25 2012-10-09 Agilent Technologies, Inc. DNA polymerase compositions for quantitative PCR and methods thereof
US7960157B2 (en) 2002-12-20 2011-06-14 Agilent Technologies, Inc. DNA polymerase blends and uses thereof
CA2519309A1 (en) * 2003-03-25 2004-10-14 Stratagene California Dna polymerase fusions and uses thereof
US7417133B2 (en) * 2004-02-27 2008-08-26 Institut Pasteur Methods for obtaining thermostable enzymes, DNA polymerase I variants from Thermus aquaticus having new catalytic activities, methods for obtaining the same, and applications of the same
DK2332977T3 (en) * 2004-07-23 2016-02-29 Acceleron Pharma Inc ActRII receptor polypeptides
US20060105348A1 (en) * 2004-11-15 2006-05-18 Lee Jun E Compositions and methods for the detection and discrimination of nucleic acids
WO2006074288A2 (en) * 2005-01-06 2006-07-13 Applera Corporation Polypeptides having nucleic acid binding activity
EP2208796B1 (de) * 2005-01-06 2014-06-18 Applied Biosystems, LLC Polypeptide mit Nukleinsäurebindungsaktivität und Zusammensetzungen und Verfahren zur Nukleinsäurenamplifikation
WO2007050125A2 (en) * 2005-05-27 2007-05-03 William Marsh Rice University High processivity polymerases
US20070117114A1 (en) * 2005-07-07 2007-05-24 Quanta Biosciences, Inc. Compositions and methods for increasing amplification efficiency
JP5241493B2 (ja) * 2005-07-15 2013-07-17 アジレント・テクノロジーズ・インク Ｄｎａ結合タンパク質−ポリメラーゼのキメラ
US20070059713A1 (en) * 2005-09-09 2007-03-15 Lee Jun E SSB-DNA polymerase fusion proteins
CA3045808C (en) 2005-11-23 2022-08-16 Acceleron Pharma, Inc. Activin-actriia antagonists and uses for promoting bone growth
US8128933B2 (en) 2005-11-23 2012-03-06 Acceleron Pharma, Inc. Method of promoting bone growth by an anti-activin B antibody
WO2007081841A2 (en) 2006-01-06 2007-07-19 Stratagene California Reaction buffer composition for nucleic acid replication with packed dna polymerases
EP2057289B1 (de) 2006-08-09 2016-08-10 Univ Singapore Verfahren für molekularbiologische anwendungen
US8895016B2 (en) 2006-12-18 2014-11-25 Acceleron Pharma, Inc. Antagonists of activin-actriia and uses for increasing red blood cell levels
ES2415666T3 (es) 2007-02-01 2013-07-26 Acceleron Pharma, Inc. Composiciones farmacéuticas que comprenden antagonistas de Activina-ActRIIa para uso en la prevención o el tratamiento de metástasis de cáncer de mama o pérdida ósea relacionada con el cáncer de mama
TW201907946A (zh) 2007-02-02 2019-03-01 美商艾瑟勒朗法瑪公司 衍生自ＡｃｔＲＩＩＢ的變體與其用途
EP2484372A1 (de) 2007-02-09 2012-08-08 Acceleron Pharma, Inc. Activin-ActRIIa-Antagonisten und Anwendungen Davon zur Forderung des Knochenwachstums Bei Krebspatienten
CA2699936A1 (en) 2007-09-18 2009-03-26 Acceleron Pharma Inc. Activin-actriia antagonists and uses for decreasing or inhibiting fsh secretion
US8338094B2 (en) 2007-11-27 2012-12-25 Bio-Rad Laboratories, Inc. Reduced inhibition of one-step RT-PCR
WO2009087394A1 (en) * 2008-01-11 2009-07-16 Genesys Ltd Cren7 chimeric protein
GB0803628D0 (en) 2008-02-28 2008-04-02 Genesys Ltd Enzyme
GB0804722D0 (en) * 2008-03-14 2008-04-16 Genesys Ltd Enzyme
GB0804721D0 (en) * 2008-03-14 2008-04-16 Genesys Ltd Enzyme
HRP20230761T1 (hr) 2008-08-14 2023-10-13 Acceleron Pharma Inc. Gdf zamke
US8216997B2 (en) 2008-08-14 2012-07-10 Acceleron Pharma, Inc. Methods for increasing red blood cell levels and treating anemia using a combination of GDF traps and erythropoietin receptor activators
JP5258512B2 (ja) * 2008-10-30 2013-08-07 株式会社日立製作所 エキソヌクレアーゼ活性増強ｄｎａポリメラーゼ変異体
JP5809059B2 (ja) 2008-11-03 2015-11-10 カパ バイオシステムズ， インコーポレイテッド 改変ａ型ｄｎａポリメラーゼ
WO2010062776A2 (en) 2008-11-03 2010-06-03 Kapabiosystems Chimeric dna polymerases
EP2382321A4 (de) 2009-01-08 2012-12-19 Bio Rad Laboratories Verfahren und zusammensetzungen zur verbesserung der wirksamkeit bei einer nukleinsäureverstärkungsreaktionen
EP3415621A1 (de) 2009-03-04 2018-12-19 Board Of Regents The University Of Texas System Stabilisierte reverse-transkriptase-fusionsproteine
US9778188B2 (en) 2009-03-11 2017-10-03 Industrial Technology Research Institute Apparatus and method for detection and discrimination molecular object
US8603792B2 (en) 2009-03-27 2013-12-10 Life Technologies Corporation Conjugates of biomolecules to nanoparticles
US8535925B2 (en) 2009-04-10 2013-09-17 Bio-Rad Laboratories, Inc. Modified DNase compositions and methods of use thereof
AU2010258931B2 (en) 2009-06-08 2015-04-23 Acceleron Pharma Inc. Methods for increasing thermogenic adipocytes
US8293881B2 (en) 2009-06-12 2012-10-23 Acceleron Pharma Inc. Isolated nucleic acid encoding a truncated ActRIIB fusion protein
US8889394B2 (en) * 2009-09-07 2014-11-18 Empire Technology Development Llc Multiple domain proteins
CN102781518A (zh) * 2009-09-09 2012-11-14 阿塞勒隆制药公司 Actriib拮抗剂及其给药和用途
JP2013505016A (ja) * 2009-09-16 2013-02-14 マッシー ユニヴァーシティー 融合ポリペプチドおよびその使用
ES2658292T3 (es) 2009-11-17 2018-03-09 Acceleron Pharma, Inc. Proteínas ActRIIB y variantes y usos de las mismas con respecto a la inducción de la utrofina para el tratamiento de la distrofia muscular
IN2012DN05145A (de) 2009-11-19 2015-10-23 Solis Biodyne
EP2539471B1 (de) 2010-02-26 2014-08-06 Life Technologies Corporation Verfahren zur sequenzierung bei verwendung einer modifizierte polymerase
US9482615B2 (en) 2010-03-15 2016-11-01 Industrial Technology Research Institute Single-molecule detection system and methods
US9670243B2 (en) 2010-06-02 2017-06-06 Industrial Technology Research Institute Compositions and methods for sequencing nucleic acids
US8865078B2 (en) 2010-06-11 2014-10-21 Industrial Technology Research Institute Apparatus for single-molecule detection
US20120070829A1 (en) 2010-09-10 2012-03-22 Bio-Rad Laboratories, Inc. Size selection of dna for chromatin analysis
US9617588B2 (en) 2010-10-05 2017-04-11 Thermo Fisher Scientific Baltics Uab Enzyme mixture
EP2638065A4 (de) 2010-11-08 2014-04-09 Acceleron Pharma Inc Actriia-bindende stoffe und ihre verwendungen
US9315787B2 (en) 2011-01-14 2016-04-19 Kapa Biosystems, Inc. Modified DNA polymerases for improved amplification
WO2012109315A1 (en) 2011-02-08 2012-08-16 Life Technologies Corporation Linking methods, compositions, systems, kits and apparatuses
EP2675913B1 (de) 2011-02-15 2016-12-14 Bio-Rad Laboratories, Inc. Erkennung von methylierung in einer subpopulation von genomischer dna
SG10201601853XA (en) 2011-03-11 2016-04-28 Univ Singapore Pericyte progenitors from peripheral blood
EP2694670B1 (de) 2011-04-08 2017-07-19 Bio-Rad Laboratories, Inc. Pcr-reaktionsgemische mit verminderter nichtspezifischer aktivität
US8715987B2 (en) 2011-05-02 2014-05-06 New England Biolabs, Inc. Solubilized phospholipids for stabilizing nucleic acid polymerases
US8921044B2 (en) 2011-05-11 2014-12-30 New England Biolabs, Inc. DNA polymerase variants with reduced exonuclease activity and uses thereof
EP2707481B1 (de) 2011-05-11 2016-07-13 New England Biolabs, Inc. Dna-polymerasevarianten mit verminderter exonukleaseaktivität und ihre anwendung
US8470573B2 (en) * 2011-06-21 2013-06-25 Bio-Rad Laboratories, Inc. Hybrid polymerases having the ability to produce long amplicons
EP2739752B1 (de) 2011-08-03 2017-07-19 Bio-Rad Laboratories, Inc. Filterung von kleinen nukleinsäuren anhand von permeabilisierten zellen
WO2014071158A1 (en) 2012-11-02 2014-05-08 Celgene Corporation Activin-actrii antagonists and uses for treating bone and other disorders
WO2015085230A1 (en) 2013-12-06 2015-06-11 Bio-Rad Laboratories, Inc. Fusion polymerases
CA2951926C (en) 2014-06-13 2023-01-10 Acceleron Pharma, Inc. Methods and compositions for treating ulcers
EP3172332B1 (de) 2014-07-22 2020-10-14 Bio-rad Laboratories, Inc. Puffer zur verwendung mit polymerasen
US10072285B2 (en) 2014-08-19 2018-09-11 Bio-Rad Laboratories, Inc. RNA amplification methods
MA41052A (fr) 2014-10-09 2017-08-15 Celgene Corp Traitement d'une maladie cardiovasculaire à l'aide de pièges de ligands d'actrii
EP3218471A1 (de) 2014-11-14 2017-09-20 Illumina, Inc. Polymerasen
EP3224359B1 (de) 2014-11-25 2023-10-25 Bio-Rad Laboratories, Inc. Arginin zur verbesserung der lagerstabilität von polymerase
ES2946160T3 (es) 2014-12-03 2023-07-13 Celgene Corp Antagonistas de activina-ActRII y usos para tratar síndrome mielodisplásico
ES2804843T3 (es) 2015-02-02 2021-02-09 Hoffmann La Roche Variantes de polimerasa
EP3486329A1 (de) 2015-02-17 2019-05-22 Bio-Rad Laboratories, Inc. Verfahren zur erzeugung und amplifizierung von cdns
WO2017050723A1 (en) 2015-09-22 2017-03-30 Genia Technologies, Inc. Pol7 polymerase variants
WO2017090685A1 (ja) * 2015-11-27 2017-06-01 国立大学法人九州大学 Ｄｎａポリメラーゼ変異体
LT3402880T (lt) 2016-01-15 2024-03-12 Thermo Fisher Scientific Baltics Uab Termofiliniai dnr polimerazės mutantai
EP3402826A1 (de) 2016-01-15 2018-11-21 Thermo Fisher Scientific Baltics UAB Antikörper zur bindung von thermophilen dna-polymerasen
ES2880331T3 (es) 2016-02-29 2021-11-24 Genia Tech Inc Variantes de polimerasa
WO2017148861A1 (en) 2016-02-29 2017-09-08 Genia Technologies, Inc. Exonuclease deficient polymerases
CN108699540A (zh) 2016-02-29 2018-10-23 吉尼亚科技公司 用于纳米孔测序的聚合酶-模板复合物
JP6720632B2 (ja) * 2016-03-29 2020-07-08 東洋紡株式会社 融合タンパク質
WO2018054970A2 (en) 2016-09-22 2018-03-29 F. Hoffmann-La Roche Ag Pol6 polymerase variants
WO2019002178A1 (en) 2017-06-26 2019-01-03 Thermo Fisher Scientific Baltics Uab DNA MUTANTS THERMOPHILIC POLYMERASES
EP3728633A1 (de) 2017-12-22 2020-10-28 Thermo Fisher Scientific Baltics Uab Polymerasekettenreaktionszusammensetzung mit aminen
WO2020056044A1 (en) * 2018-09-11 2020-03-19 Singular Genomics Systems, Inc. Modified archaeal family b polymerases
CN109266628B (zh) * 2018-10-09 2020-04-14 南京市胸科医院 一种融合的TaqDNA聚合酶及其应用
US10934533B1 (en) 2018-10-10 2021-03-02 New England Biolabs, Inc. Variant DNA polymerases having improved properties and method for improved isothermal amplification of a target DNA
CN109679932B (zh) * 2018-12-05 2020-03-17 广州奇辉生物科技有限公司 一种dna聚合酶、重组载体及它们的制备方法和应用
CN112175091A (zh) * 2019-07-05 2021-01-05 赛纳生物科技(北京)有限公司 通过功能结构域嫁接提高聚合酶大片段活性的方法及应用
US11512295B2 (en) 2019-09-12 2022-11-29 Singular Genomics Systems, Inc. Modified thermoccocus polymerases
WO2021163561A1 (en) 2020-02-13 2021-08-19 New England Biolabs, Inc. Variant family d dna polymerases
EP4103702A1 (de) 2020-02-13 2022-12-21 New England Biolabs, Inc. Varianten der d-dna-polymerasen
US11034942B1 (en) 2020-02-27 2021-06-15 Singular Genomics Systems, Inc. Modified pyrococcus polymerases and uses thereof
CN111518873A (zh) * 2020-05-11 2020-08-11 南京君华基因科技有限公司 一种优化的扩增目标核酸的方法及应用
PL241698B1 (pl) * 2021-01-27 2022-11-21 Inst Biotechnologii I Medycyny Molekularnej Polimeraza Pwo-NeqSSB, sposób jej otrzymywania, plazmid rekombinantowy, startery oraz zastosowanie polimerazy
US11486001B2 (en) 2021-02-08 2022-11-01 Singular Genomics Systems, Inc. Methods and compositions for sequencing complementary polynucleotides
WO2022250676A1 (en) 2021-05-27 2022-12-01 New England Biolabs, Inc. Dnase i variants, compositions, methods, and kits
US11667968B2 (en) 2021-05-27 2023-06-06 New England Biolabs, Inc. Fragmentation of DNA
WO2022249133A1 (en) 2021-05-28 2022-12-01 Erebus Enzymes Inc. Ultra-processive, stutter-resistant polymerase system
WO2023089175A1 (en) 2021-11-22 2023-05-25 F. Hoffmann-La Roche Ag Thermostable polymerase variants
WO2023146243A1 (ko) * 2022-01-26 2023-08-03 주식회사 씨젠 샘플 내 타겟 핵산을 검출하는 방법

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2069948A1 (en) * 1989-12-01 1991-06-02 Brian Wylie Pontius Promotion of high specificity molecular assembly
US5747911A (en) 1994-09-30 1998-05-05 Itt Automotive Electrical Systems, Inc. Brush holder
US5972603A (en) * 1996-02-09 1999-10-26 President And Fellows Of Harvard College DNA polymerase with modified processivity
US6228628B1 (en) 1997-07-09 2001-05-08 Roche Molecular Systems Mutant chimeric DNA polymerase
DE19810879A1 (de) * 1998-03-13 1999-09-16 Roche Diagnostics Gmbh Polymerasenchimären
DE19840771A1 (de) * 1998-08-06 2000-02-10 Lion Bioscience Ag Thermostabiler in vitro-Komplex mit Polymeraseaktivität
EP1100923A2 (de) * 1998-08-06 2001-05-23 LION Bioscience AG Thermostabiler in vitro-komplex mit polymeraseaktivität
DE60133992D1 (de) 2000-02-17 2008-06-26 Qiagen Gmbh Thermostabile chimäre nucleinsäurepolymerasen und ihre verwendungen
US6627424B1 (en) 2000-05-26 2003-09-30 Mj Bioworks, Inc. Nucleic acid modifying enzymes

Also Published As

Publication number Publication date
CA2409417C (en) 2014-12-09
US20030162173A1 (en) 2003-08-28
US10066218B2 (en) 2018-09-04
AU2001275039B2 (en) 2006-07-13
US10954495B2 (en) 2021-03-23
WO2001092501A1 (en) 2001-12-06
US7670808B2 (en) 2010-03-02
EP1283875A1 (de) 2003-02-19
AU7503901A (en) 2001-12-11
US20140038237A1 (en) 2014-02-06
US20030148330A1 (en) 2003-08-07
CA2409417A1 (en) 2001-12-06
US8900846B2 (en) 2014-12-02
US20130203119A1 (en) 2013-08-08
US20040191825A1 (en) 2004-09-30
JP2010000089A (ja) 2010-01-07
JP2003534796A (ja) 2003-11-25
US6627424B1 (en) 2003-09-30
US7541170B2 (en) 2009-06-02
US9453208B2 (en) 2016-09-27
EP1283875A4 (de) 2004-12-29
US8895283B2 (en) 2014-11-25
US20110165654A1 (en) 2011-07-07
US8415129B2 (en) 2013-04-09
DE60129549T2 (de) 2008-04-24
US20170198267A1 (en) 2017-07-13
ES2291322T3 (es) 2008-03-01
US7919296B2 (en) 2011-04-05
US20190078066A1 (en) 2019-03-14
DK1283875T3 (da) 2007-11-26
EP1283875B1 (de) 2007-07-25
JP4405725B2 (ja) 2010-01-27
US20150218536A1 (en) 2015-08-06
ATE368104T1 (de) 2007-08-15

Similar Documents

Publication Publication Date Title
ATE368104T1 (de) Verbesserte nukleinsäure-modifizierende enzyme
ES2311638T3 (es) Metodos de empleo mejorado de polimerasa.
ATE373086T1 (de) Enzyme des auf die lysosomen gerichteten weges
ATE458832T1 (de) Paralleles scoring von polymorphismen mittels amplifikation und fehlerkorrektur
ATE431416T1 (de) Enzymatische synthese von deoxyribonucleotiden
DE60219579D1 (de) Reversibel modifizierte thermostabile Enzyme für die in vitro-Synthese und -Amplifizierung von DNA
DE60038886D1 (de) Neue enzyme, welche glycerin entwässern
AU2001254620A1 (en) Lipolytic enzyme variant
BRPI0412328A (pt) aditivo de alimentos que compreende variantes exomilase não maltogênicas de pseudomonas
ATE490311T1 (de) Mutanten der alpha-amylase
WO2002016583A3 (en) Constructs and their use in metabolic pathway engineering
ATE268379T1 (de) Enzym mit aminopeptidaseactivität
ATE357272T1 (de) Verwendung von phthalazin-derivaten zur behandlung neurodegenerativer krankheiten
NZ515673A (en) Compositions and methods for labeling of nucleic acid molecules
DE60223377D1 (de) Veränderung von pilzen zur verwendung von l-arabinose
ES2166010T3 (es) Produccion de acrilato de amonio.
TR200101497T2 (tr) Lipolitik enzim varyantları
DE69736975D1 (de) Enzym mit galaktanaseaktivität
AU7275498A (en) Laundry detergent and/or fabric care compositions comprising a modified enzyme
ATE338132T1 (de) Fettsäure-elongase-3-ketoacyl-coa-synthase- polypeptide
DE60222390D1 (de) Verbessertes in-vitro-synthesesystem
EP1832652A3 (de) Verbesserte Nukleinsäure-modifizierende Enzyme
DE69728863D1 (de) Enzym mit pektin-esterase-aktivität
PT1196606E (pt) Enzima litica
WO2003068907A3 (en) Method for the generation of proteins with new enzymatic function

Legal Events

Date Code Title Description
8364 No opposition during term of opposition